{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:27:28Z","timestamp":1785878848244,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL110837"],"award-info":[{"award-number":["T32HL110837"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.pcad.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T20:42:54Z","timestamp":1732912974000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword"],"prefix":"10.1016","volume":"91","author":[{"given":"Evan L.","family":"O'Keefe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam","family":"Abuissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Metzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pcad.2024.11.003_bb0005","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjqcco\/qcaa061","article-title":"Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: results from the global burden of disease study 2017","volume":"7","author":"Dai","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"25","key":"10.1016\/j.pcad.2024.11.003_bb0010","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.121.055654","article-title":"Effect of long-term marine \u0277-3 fatty acids supplementation on the Risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and Meta-analysis","volume":"144","author":"Gencer","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2024.11.003_bb0015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10557-021-07204-z","article-title":"Association between Omega-3 fatty acid treatment and atrial fibrillation in cardiovascular outcome trials: a systematic review and Meta-analysis","volume":"35","author":"Jia","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"10.1016\/j.pcad.2024.11.003_bb0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jacc.2023.05.024","article-title":"Omega-3 fatty acids biomarkers and incident atrial fibrillaton: an individual participant-level pooled analysis of 17 international prospective studies","volume":"82","author":"Qian","year":"2023","journal-title":"JACC"},{"issue":"12","key":"10.1016\/j.pcad.2024.11.003_bb0025","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1093\/jn\/nxac178","article-title":"DHA supplementation during pregnancy enhances maternal Vagally mediated cardiac autonomic control in humans","volume":"152","author":"Christifano","year":"2023","journal-title":"J Nutr"},{"issue":"8","key":"10.1016\/j.pcad.2024.11.003_bb0030","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjcard.2005.11.025","article-title":"Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions","volume":"97","author":"O\u2019Keefe","year":"2006","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2024.11.003_bb0035","doi-asserted-by":"crossref","first-page":"11454","DOI":"10.1038\/s41598-023-38344-x","article-title":"A randomized clinical trial of omega-3 fatty acid and vitamin D supplementation on electrocardiographic risk profiles","volume":"13","author":"Tikkanen","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.pcad.2024.11.003_bb0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jacep.2019.11.008","article-title":"TREAT AF (transcutaneous electrical Vagus nerve stimulation to suppress atrial fibrillation): a randomized clinical trial","volume":"6","author":"Stavrakis","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"2 Pt 2","key":"10.1016\/j.pcad.2024.11.003_bb0045","first-page":"H805","article-title":"Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity","volume":"273","author":"Liu","year":"1997","journal-title":"Am J Physiol"},{"issue":"11","key":"10.1016\/j.pcad.2024.11.003_bb0050","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2021.1489","article-title":"Effect of marine Omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation: a randomized clinical trial","volume":"325","author":"Albert","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.pcad.2024.11.003_bb0055","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurjhf\/hft103","article-title":"N-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial","volume":"15","author":"Aleksova","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"10.1016\/j.pcad.2024.11.003_bb0060","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1804989","article-title":"Effects of n-3 fatty acid supplements in diabetes mellitus","volume":"379","author":"Group ASC","year":"2018","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.pcad.2024.11.003_bb0065","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1205409","article-title":"Collaborative G, Roncaglioni MC, et al. n-3 fatty acids in patients with multiple cardiovascular risk factors","volume":"368","author":"Risk","year":"2013","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.pcad.2024.11.003_bb0070","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1001\/jama.2020.16909","article-title":"Effect of vitamin D supplementation, Omega-3 fatty acid supplementation, or a Strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical trial","volume":"324","author":"Bischoff-Ferrari","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pcad.2024.11.003_bb0075","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.120.052209","article-title":"Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial","volume":"143","author":"Kalstad","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2024.11.003_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular Risk reduction with Icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.pcad.2024.11.003_bb0085","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose Omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular Risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.pcad.2024.11.003_bb0090","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.clnu.2023.07.002","article-title":"Omega-3 fatty acid supplements and risk of atrial fibrillation and \u201cmicro-atrial fibrillation\u201d: a secondary analysis from the OMEMI trial","volume":"42","author":"Myhre","year":"2023","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.pcad.2024.11.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.005033","article-title":"N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials","volume":"2","author":"Mariani","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.pcad.2024.11.003_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13649","article-title":"Omega-3 fatty acids in adipose tissue and risk of atrial fibrillation","volume":"52","author":"Rix","year":"2022","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.pcad.2024.11.003_bb0105","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.amjcard.2009.11.039","article-title":"Dietary fish intake and incident atrial fibrillation (from the Women\u2019s Health Initiative)","volume":"105","author":"Berry","year":"2010","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2024.11.003_bb0110","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ahj.2005.07.029","article-title":"Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam study","volume":"151","author":"Brouwer","year":"2006","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.pcad.2024.11.003_bb0115","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3945\/jn.115.212860","article-title":"Dietary fat intake is differentially associated with Risk of paroxysmal compared with sustained atrial fibrillation in women","volume":"145","author":"Chiuve","year":"2015","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.pcad.2024.11.003_bb0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ajcn\/81.1.50","article-title":"N-3 fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish diet, Cancer, and Health study","volume":"81","author":"Frost","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.pcad.2024.11.003_bb0125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.clnu.2016.01.019","article-title":"Fish, long-chain omega-3 polyunsaturated fatty acid intake and incidence of atrial fibrillation: a pooled analysis of two prospective studies","volume":"36","author":"Larsson","year":"2017","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.pcad.2024.11.003_bb0130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/01.CIR.0000138154.00779.A5","article-title":"Fish intake and risk of incident atrial fibrillation","volume":"110","author":"Mozaffarian","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2024.11.003_bb0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3945\/ajcn.110.001305","article-title":"Dietary factors and incident atrial fibrillation: the Framingham heart study","volume":"93","author":"Shen","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.pcad.2024.11.003_bb0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ajcnut.2023.06.001","article-title":"Dietary omega-3 fatty acids and the incidence of atrial fibrillation in the million veteran program","volume":"118","author":"Guardino","year":"2023","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.pcad.2024.11.003_bb0145","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/europace\/euu019","article-title":"A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation\/atrial flutter-a Danish cohort study","volume":"16","author":"Rix","year":"2014","journal-title":"Europace"},{"issue":"14","key":"10.1016\/j.pcad.2024.11.003_bb0150","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/eurjpc\/zwac192","article-title":"Habitual fish oil supplementation and the risk of incident atrial fibrillation: findings from a large prospective longitudinal cohort study","volume":"29","author":"Zhang","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.pcad.2024.11.003_bb0155","article-title":"Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study","author":"Li","year":"2020","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.pcad.2024.11.003_bb0160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.mayocp.2023.11.026","article-title":"Circulating docosahexaenoic acid and risk of all-cause and cause-specific mortality","volume":"99","author":"O\u2019Keefe","year":"2024","journal-title":"Mayo Clin Proc"},{"issue":"84","key":"10.1016\/j.pcad.2024.11.003_bb0165","article-title":"Omega-3 polyunsaturated fatty acids and heart rate variability","volume":"2","author":"Christensen","year":"2011","journal-title":"Front Physiol"},{"issue":"102206","key":"10.1016\/j.pcad.2024.11.003_bb0170","article-title":"Higher omega-3 index is associated with more rapid heart rate recovery in healthy men and women","volume":"163","author":"Farrell","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"13","key":"10.1016\/j.pcad.2024.11.003_bb0175","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.105.556886","article-title":"Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials","volume":"112","author":"Mozaffarian","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.11.003_bb0180","doi-asserted-by":"crossref","unstructured":"Rattanawong P, Kewcharoen J, K SS, Shen WK. Drug therapy for Vagally-mediated atrial fibrillation and Sympatho-vagal balance in the genesis of atrial fibrillation: a review of the current literature. J Atr Fibrillat 2020;13(1):2410. doi:https:\/\/doi.org\/10.4022\/jafib.2410.","DOI":"10.4022\/jafib.2410"},{"issue":"7","key":"10.1016\/j.pcad.2024.11.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254107","article-title":"Prognostic value of heart rate variability in patients with coronary artery disease in the current treatment era","volume":"16","author":"Vuoti","year":"2021","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.pcad.2024.11.003_bb0190","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.hrthm.2008.10.043","article-title":"Relationship between right cervical vagus nerve stimulation and atrial fibrillation inducibility: therapeutic intensities do not increase arrhythmogenesis","volume":"6","author":"Zhang","year":"2009","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.pcad.2024.11.003_bb0195","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/CIRCEP.109.868331","article-title":"Low-level vagosympathetic stimulation: a paradox and potential new modality for the treatment of focal atrial fibrillation","volume":"2","author":"Li","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"22","key":"10.1016\/j.pcad.2024.11.003_bb0200","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1113\/JP274678","article-title":"Defining the neural fulcrum for chronic vagus nerve stimulation: implications for integrated cardiac control","volume":"595","author":"Ardell","year":"2017","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.pcad.2024.11.003_bb0205","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/STROKEAHA.123.044281","article-title":"Omega-3 blood levels and stroke Risk: a pooled and harmonized analysis of 183,291 participants from 29 prospective studies","volume":"55","author":"O\u2019Keefe","year":"2023","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.pcad.2024.11.003_bb0210","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacc.2023.05.026","article-title":"Omega-3 fatty acids and Risk for atrial fibrillation: big fish or small fry?","volume":"82","author":"Ballantyne","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.pcad.2024.11.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.026756","article-title":"Cardiovascular benefits of Icosapent ethyl in patients with and without atrial fibrillation in REDUCE-IT","volume":"12","author":"Olshansky","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"4\u201310","key":"10.1016\/j.pcad.2024.11.003_bb0220","first-page":"142","article-title":"Association of reported fish intake and supplementation status with the omega-3 index","author":"Jackson","year":"2019","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"10.1016\/j.pcad.2024.11.003_bb0225","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ajcn\/nqz161","article-title":"Predicting the effects of supplemental EPA and DHA on the omega-3 index","volume":"110","author":"Walker","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"102418","key":"10.1016\/j.pcad.2024.11.003_bb0230","article-title":"Red blood cell fatty acid patterns from 7 countries: focus on the Omega-3 index","volume":"179","author":"Schuchardt","year":"2022","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"132\u2013152","key":"10.1016\/j.pcad.2024.11.003_bb0235","first-page":"63","article-title":"Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults","author":"Stark","year":"2016","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.pcad.2024.11.003_bb0240","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/CIR.0000000000000574","article-title":"Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: a science advisory from the American Heart Association","volume":"138","author":"Rimm","year":"2018","journal-title":"Circulation"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062024001683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062024001683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:51:07Z","timestamp":1776833467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062024001683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":48,"alternative-id":["S0033062024001683"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2024.11.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}